Concepedia

Puja Sapra

PS

Statistics

Publications

41

Citations

3.4K

H-Index

28

Active since

1998

Affiliations

Pfizer (United States)(Current)

Enzon Pharmaceuticals (United States)

University of Alberta

Connecticut Sea Grant

Pearl River Community College

Puja Sapra is an author at Pfizer (United States) specializing in pharmacology, oncology, and medicine.

ORCID

Publications per year

1998–2023

41

Publications

41

A general approach to site-specific antibody drug conjugates

Feng Tian, Yingchun Lu, Anthony Manibusan et al. · Proceedings of the National Academy of Sciences · 2014 · 317 citations · Full text

, , +17

Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs.

Puja Sapra, Theresa M. Allen · PubMed · 2002 · 243 citations

, , +17

A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth

Lee M. Greenberger, Ivan D. Horak, David Filpula et al. · Molecular Cancer Therapeutics · 2008 · 242 citations · Full text

, , +16

Novel Prodrugs of SN38 Using Multiarm Poly(ethylene glycol) Linkers

Hong Zhao, Belen Rubio, Puja Sapra et al. · Bioconjugate Chemistry · 2008 · 187 citations

, , +13

Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys

Puja Sapra, Rhona Stein, J. Pickett et al. · Clinical Cancer Research · 2005 · 169 citations

, , +17

1–5 of 41